Truvada Approval History
FDA Approved: Yes (First approved August 2, 2004)
Brand name: Truvada
Generic name: emtricitabine and tenofovir
Dosage form: Tablets
Company: Gilead Sciences, Inc.
Treatment for: HIV Infection, Pre-Exposure Prophylaxis
Truvada (emtricitabine and tenofovir disoproxil fumarate) is a combination of nucleoside analog HIV-1 reverse transcriptase inhibitors indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection, and for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in people at high risk.
Development History and FDA Approval Process for Truvada
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.